Back to Transactions
Healthcare
2019

MI Bioresearch has been sold to Covance, a subsidiary of LabCorp

MI Bioresearch is a leading preclinical immuno-oncology / oncology contract research organization, offering a unique combination of complementary services. It supports preclinical research for a diverse pharmaceutical and biotechnology customer base. It offers a broad range of human cell line and syngeneic models, supported by an array of in vitro services, in vivo pharmacology, in vivo imaging and focal beam radiation. MI Bioresearch’s comprehensive, differentiated business model leverages this range of services to better interrogate the complex pharmacology associated with cancer to provide higher-quality, decision-enabling data to its customers. For more information, visit www.mibioresearch.com.

Lincoln International acted as the exclusive investment banking advisor for MI Bioresearch and its shareholders, working closely with the company’s management team and shareholders throughout the sale process. This included creating a customized process strategy, developing the positioning, managing the buyer outreach, organizing due diligence and negotiating the transaction.

About Covance

Covance is a comprehensive drug development company. Covance offers laboratory testing services to the chemical / agrochemical industries and is a market leader in toxicology services, central laboratory services, discovery services and a top global provider of Phase III clinical trial management services. For more information, visit www.covance.com.

About LabCorp

LabCorp, an S&P 500 listed company, is a leading life sciences company, providing comprehensive clinical laboratory and end-to-end drug development services. LabCorp delivers diagnostic solutions, brings innovative medicines to patients and develops technology-enabled solutions. For more information, visit www.labcorp.com.

Related
Perspectives

Connect with a Senior Team Member

Meet our Senior Team

Fatheazam Shahab
The healthcare market is ever-changing and increasingly complex and always puts one in touch with exceptional people of many talents.

Shahab Fatheazam

Vice Chairman | Healthcare

Chicago

Honesty and integrity are very important to me. I have a genuine interest in learning about clients and their businesses, as well as pushing myself to continuously evolve in my role as a valued advisor.

Cynthya Goulet

Managing Director

Chicago

Max Golembo
I foster long-term relationships with my clients through trust, transparency and clear communication.

Max Golembo

Vice President

Chicago

View More Transactions in Healthcare

Lincoln International advised Crédit Mutuel Equity on the sale of Technoflex to Adagia Partners

Healthcare

Lincoln International advised UPSA on the acquisition of Sérélys Pharma

Healthcare

Lincoln International advised Phoenix Equity Partners in completing a multi-asset continuation vehicle transaction involving Nineteen Group and Envisage Dental

Healthcare

Lincoln International advised OceanSound Partners on the acquisition of PAR Excellence from Northlane Capital Partners

Healthcare

Lincoln International advised Audax Private Equity on the sale of Chartis to Blackstone Growth

Business Services | Healthcare

Lincoln International advised Hobson & Motzer on its sale to Vantedge, a portfolio company of Aterian

Healthcare

Lincoln International advised HUMANOO on its sale to TELUS Health

Healthcare

Lincoln International advised Eetgemak Group, a portfolio company of Gilde Healthcare, on the acquisition of TotaalVERS

Consumer | Healthcare
View All

Any information or testimonials contained in this post may not be representative of the experience of other clients and is no guarantee of future performance or success.